Delivery Order SPE2DB22D3301-SPE2DB24FX6ET
Award Date
11/30/23
Potential Completion Date
12/1/23
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,328.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for MESALAMINE DR 1.2 GM TABLET 120S, with a firm fixed price and an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $8,747.04 firm-fixed-price delivery order is for the supply of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The award has an ultimate completion date of September 11, 2023. The contract is not designated as a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,785.70, is a delivery order for MESALAMINE DR 1.2 GM TABLET 120S. The contract is a Firm Fixed Price award with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, identified as SPE2DB20D3104 and SPE2DB23FV9C1, is a Firm Fixed Price Delivery Order contract valued at $9,490.48. The contract provides 4562312315 MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product, to support military treatment facilities and other federal healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, holds...
This federal contract award, valued at $5,529.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567722359 MESALAMINE DR 1.2 GM TABLET 120S, a medical product, and has an ultimate completion date of March 31, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of MESALAMINE DR 1.2 GM TABLET 120S. The $1,951.60 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical division. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $31,379.54 firm fixed-price delivery order is for the supply of 4557537625 - Mesalamine DR 1.2 GM Tablet 120S. This is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $1,181.45 for the provision of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has a completion date of June 4, 2024 and is a Firm Fixed Price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,783,304 tablets of Mesalamine DR 1.2 GM, a pharmaceutical product, with a ceiling value of $9,696.97 and a completion date of May 2, 2023. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, valued at $3,875.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for MESALAMINE DR 1.2 GM TABLET 120S, a medication used to treat gastrointestinal conditions. The contract has a firm fixed-price pricing type and an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...